A joint effort against the Oriental boil

This release is also available in German.

Leishmaniasis is a disease with many names. In the Mediterranean region, where it frequently occurs, it is also known as the Aleppo or Oriental boil. It is caused by various species of leishmania (parasites) and results in very different clinical presentations. In all cases the consequences are severe tissue damage of the skin or the internal organs. With the support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), a trilateral research unit composed of German, Israeli and Palestinian doctors, biologists and ecologists has been studying the causative agents of leishmania, possible transmission pathways and remedies for the past five years. Despite partially difficult external circumstances, the interdisciplinary research in the Near East was successful: It has already yielded a series of results that can contribute to combating the disease.

The Oriental boil, the symptom of the ancient infectious disease called leishmaniasis cutis (cutaneous leishmaniasis), is hardly known in Germany. In contrast, in many countries of Asia and South America leishmaniasis occurs frequently; its incidence has even been increasing in the Near East and India over the past few years. The main vector of the disease is the two-millimetre long sand fly. A single bite is sufficient to cause an infection. A vaccine or medicinal preventive care is not yet available. Treatment of leishmaniasis is difficult: It is associated with side effects and is expensive which means that it cannot be afforded by poor patients.

In Israel and the Palestinian areas three species of leishmaniasis-causing agents occur which present different clinical pictures and are associated with different vectors and hosts. In 1998 a project funded by the DFG began in which scientists from Germany, Israel and the Palestinian areas are jointly studying this disease. Th

Contact: Jost-Gert Glombitza
Deutsche Forschungsgemeinschaft

Page: 1 2 3 4

Related biology news :

1. Aged roaches experience perils of stiff joints, find Case researchers
2. Standard helps control quality of joint replacements
3. UIC researchers create tissue-engineered joint from stem cells
4. ENBREL combo therapy inhibits joint damage progression, offers significant RA symptom relief
5. Flexible joints associated with chronic fatigue syndrome, researchers find
6. First joint meeting between ESA and SER
7. Quadrennial joint annual meetings of American Society of Plant Biologists and Canadian Society of Plant Physiologists in Providence July 21-25 will present latest advances in plant science
8. With first comparative look at human and mouse DNA, joint genome institute team confirms gene estimate
9. Johns Hopkins Medicine, Toshiba establish joint research program, training center, in interventional radiology department
10. UW, PNNL think big, aim small with creation of joint nanotechnology institute
11. New data suggest anakinra may accelerate reduction in joint destruction and improve quality of life for rheumatoid arthritis patients

Post Your Comments:

(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio ... findings of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease ... hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this ...
(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... announced that it has entered into a multi-year contract with Merus N.V., ... their translational and clinical research strategy to discover and develop ground-breaking drugs. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... sciences industry, today announced the release of its signature product called Beacon ... Liaisons (MSLs) and other field medical professionals. , Beacon helps MSLs ...
(Date:7/18/2020)... ... , ... “We are thrilled to deliver this new technology to the industry” ... kind on the market and we were pleased that the IFT jury recognized that.” ... ingredients, creating a natural way to extend the shelf life and improve the safety ...
(Date:7/10/2020)... LORTON, Va. (PRWEB) , ... July 08, 2020 ... ... laboratory testing services and products, announces a significant expansion of laboratory operations through ... robust collection for agencies implementing testing programs. , Bode-CARES provides ...
Breaking Biology Technology:
Cached News: